Sierra Summit Advisors »

Arrowhead Pharmaceuticals shares owned by Sierra Summit Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Sierra Summit Advisors from 13F filings

Historical chart of Sierra Summit Advisors investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Sierra Summit Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Sierra Summit Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $900k 14k 62.70

More positions owned by Sierra Summit Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Lumentum Hldgs (LITE)
Eli Lilly & Co. (LLY)
Citigroup Com New (C)
Vertiv Holdings Com Cl A (VRT)
Amazon (AMZN)
Ge Vernova (GEV)
Chevron Corporation (CVX)
Rocket Cos Com Cl A (RKT)
Robinhood Mkts Com Cl A (HOOD)
Meta Platforms Cl A (META)
Deere & Company (DE)

View all positions for Sierra Summit Advisors

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Vanguard Portfolio Management
FMR
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Fred Alger Management
Invesco
Slate Path Capital
Vestal Point Capital
Arrowstreet Capital, Limited Partnership
Baker Bros. Advisors
Driehaus Capital Management

View all funds holding Arrowhead Pharmaceuticals